8-K: Cannabist Company Reports Mixed Q4 and Full Year 2024 Results Amidst Restructuring

The Cannabist Company announced its Q4 and full year 2024 financial results, highlighting revenue declines due to asset sales but also cost savings from corporate restructuring.

Summary

• The Cannabist Company reported its financial results for the fourth quarter and full year ended December 31, 2024.
• Q4 revenue was $96.1 million, a 16% decrease from the previous quarter, primarily due to the sale of businesses in Eastern Virginia and Arizona, as well as 14 stores in Florida.
• Full year revenue was $458.7 million, compared to $511.3 million in the previous year.
• The company achieved $23 million in annualized cost savings through corporate restructuring during 2024.
• Adjusted EBITDA for Q4 was $7.0 million, down from $14.8 million in Q3, largely due to asset sales and pricing pressure.
• The company ended the quarter with $33.6 million in cash, up from $31.5 million at the end of Q3.
• The company has an agreement to extend the maturities on its senior secured debt until December 2028, with options to extend through 2029.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company is implementing cost-saving measures and restructuring its debt, revenue and EBITDA have declined. The future outlook is cautiously optimistic.

Positives

• The company achieved $23 million in annualized cost savings through corporate restructuring.
• The company ended Q4 with $33.6 million in cash, up from $31.5 million at the end of Q3.
• The company achieved positive operating cash flow of $4.3 million in Q4 2024.
• The company has an agreement to extend the maturities on its senior secured notes to December 2028, with options to extend through 2029.
• For FY 2024, wholesale revenue increased 11% over 2023.

Negatives

• Q4 revenue decreased 16% sequentially to $96.1 million due to asset sales.
• Full year revenue decreased to $458.7 million from $511.3 million.
• Adjusted EBITDA in Q4 was $7.0 million, down from $14.8 million in Q3.
• Q4 results were impacted by a $3.1 million provision for credit losses and a $2.1 million intangible impairment.
• Gross Margin in the fourth quarter was 35%, down sequentially.

Risks

• The company's performance is subject to the risks associated with the cannabis industry, including regulatory changes and market volatility.
• The company's ability to execute its restructuring plan and achieve cost savings is subject to various risks and uncertainties.
• The company faces pricing pressure in several key markets.
• The company's future performance depends on its ability to manage its balance sheet and maintain liquidity.

Future Outlook

The company's mandate in 2025 is to continue to simplify its business, maintain liquidity, improve margins, and drive cash flow generation, putting it in a position to succeed, with catalysts including adult use transition in Delaware and new retail locations in Virginia and Ohio.

Management Comments

• David Hart, CEO of The Cannabist Company, stated that the debt restructuring provides runway to focus on optimizing the business.
• David Hart, CEO of The Cannabist Company, stated that the company's mandate in 2025 is to continue to simplify its business, maintain liquidity, improve margins, and drive cash flow generation, putting us in a position to succeed.

Industry Context

The Cannabist Company's results reflect the ongoing challenges and opportunities in the cannabis industry, including market consolidation, regulatory changes, and increasing competition. The company's focus on cost savings and balance sheet management is consistent with the strategies of other cannabis companies in the current environment.

Comparison to Industry Standards

• Comparing Cannabist's performance to peers like Curaleaf, Trulieve, and Green Thumb Industries, its revenue decline reflects a broader trend of market adjustments and strategic realignments within the cannabis sector.
• While some competitors have focused on aggressive expansion, Cannabist's emphasis on streamlining operations and reducing debt mirrors a more conservative approach seen in companies like Cresco Labs, which are prioritizing profitability and cash flow generation.
• The adjusted EBITDA margins of Cannabist are within the range of other multi-state operators, but the company's focus on wholesale revenue growth aligns with strategies employed by companies like Canopy Growth, which are diversifying revenue streams beyond retail sales.

Stakeholder Impact

• Shareholders may be concerned about the decline in revenue and EBITDA, but reassured by the debt restructuring and cost-saving measures.
• Employees may be affected by the corporate restructuring and potential job losses.
• Customers may experience changes in the availability of products and services due to asset sales and store closures.
• Suppliers may be impacted by the company's efforts to optimize its supply chain.

Next Steps

• The company will continue to focus on simplifying its business, maintaining liquidity, improving margins, and driving cash flow generation.
• The company plans to open additional retail locations in Virginia and Ohio.
• The company will continue to execute on divestiture transactions.

Key Dates